Blog articles

Post-stroke and mini-stroke prescribing: NICE calls for comments

NICE is inviting comments around genomic testing for post-stroke prescriptions of clopidogrel ahead of its treatment-influencing July publication

NHS patients to get 'early access' to new RNA cancer vaccines

NHS cancer patients will be able to access emerging RNA-based immunotherapies thanks to a newly announced partnership between BioNTech and the government

The NHS's new strategy for genomics: Five key takeaways

We look at the new ‘Accelerating genomic medicine in the NHS’ report and what it means for healthcare professionals
A human egg being fertilised using IVF

Polygenic scores and PGT: a problematic pairing

We explore a new type of test hitting the headlines and ask whether it could ever be approved for UK clinics

Implementing genomics across the UK

We explore a new paper that sets out the UK’s genomics healthcare plan for the next three years

Personalised prescribing report: five things we learned

We share some key highlights from this week’s landmark pharmacogenomics report

Genomics Beyond Health: a new report

We step away from the healthcare sector this week to look at the bigger genomics picture
Medication on a pharmacy shelf

NHS to launch Innovative Medicines Fund

We look at an initiative that could change the lives of people with rare diseases by giving them access to cutting-edge treatments
Old pictures in a pile. No recognisable faces or text.

DTC testing: time to step in?

As DTC testing becomes more accessible and popular than ever, we ask whether more regulatory work could – and should – be done 

Genomics in the NHS

This #GenomicsConversation week, we look at the genomics landscape in the UK today and the 10-year plan for the future

AI in the NHS: what do health professionals need to know?

Can artificial intelligence help bring about personalised and preventative healthcare? AI expert Jessica Morley sums up the 4 key considerations for NHS staff

Pharmacogenomics: three challenges to the NHS

Last week we explored the promise of pharmacogenomics in the health service, but there are good reasons why it will take time to implement